RESUMO
BACKGROUND: In 2021, four patients who had received solid organ transplants in the USA developed encephalitis beginning 2-6 weeks after transplantation from a common organ donor. We describe an investigation into the cause of encephalitis in these patients. METHODS: From Nov 7, 2021, to Feb 24, 2022, we conducted a public health investigation involving 15 agencies and medical centres in the USA. We tested various specimens (blood, cerebrospinal fluid, intraocular fluid, serum, and tissues) from the organ donor and recipients by serology, RT-PCR, immunohistochemistry, metagenomic next-generation sequencing, and host gene expression, and conducted a traceback of blood transfusions received by the organ donor. FINDINGS: We identified one read from yellow fever virus in cerebrospinal fluid from the recipient of a kidney using metagenomic next-generation sequencing. Recent infection with yellow fever virus was confirmed in all four organ recipients by identification of yellow fever virus RNA consistent with the 17D vaccine strain in brain tissue from one recipient and seroconversion after transplantation in three recipients. Two patients recovered and two patients had no neurological recovery and died. 3 days before organ procurement, the organ donor received a blood transfusion from a donor who had received a yellow fever vaccine 6 days before blood donation. INTERPRETATION: This investigation substantiates the use of metagenomic next-generation sequencing for the broad-based detection of rare or unexpected pathogens. Health-care workers providing vaccinations should inform patients of the need to defer blood donation for at least 2 weeks after receiving a yellow fever vaccine. Despite mitigation strategies and safety interventions, a low risk of transfusion-transmitted infections remains. FUNDING: US Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority, and the CDC Epidemiology and Laboratory Capacity Cooperative Agreement for Infectious Diseases.
Assuntos
Encefalite , Transplante de Órgãos , Vacina contra Febre Amarela , Humanos , Transfusão de Sangue , Encefalite/induzido quimicamente , Transplante de Órgãos/efeitos adversos , Estados Unidos/epidemiologia , Vírus da Febre Amarela/genéticaRESUMO
CONTEXT: - Human papillomavirus (HPV) has a well-known role in the pathogenesis of squamous cell carcinoma and precursor lesions of the cervix, anogenital region, and head and neck, but its role in the development of squamous neoplasms of the eye, particularly the conjunctiva, remains unclear. OBJECTIVE: - To review recent evidence implicating HPV in the pathophysiology of ocular lesions. DATA SOURCES: - Published articles obtained from a PubMed search of the English literature were the primary sources for this review. CONCLUSIONS: - The low-risk HPV types 6 and 11 appear to play a role in the development of at least a subset of conjunctival squamous papillomas. The role of HPV in the pathogenesis of pterygium and ocular surface squamous neoplasia is less well defined. There is evidence to suggest that HPV may be a cofactor in the development of these lesions, acting in concert with ultraviolet radiation and/or human immunodeficiency virus infection in a subgroup of cases.
Assuntos
Carcinoma de Células Escamosas/virologia , Neoplasias Oculares/virologia , Papillomaviridae/fisiologia , Infecções por Papillomavirus/virologia , Pterígio/virologia , Carcinoma de Células Escamosas/fisiopatologia , Neoplasias da Túnica Conjuntiva/fisiopatologia , Neoplasias da Túnica Conjuntiva/virologia , Neoplasias Oculares/fisiopatologia , Papillomavirus Humano 11/fisiologia , Papillomavirus Humano 16/fisiologia , Humanos , Papiloma/fisiopatologia , Papiloma/virologia , Infecções por Papillomavirus/fisiopatologia , Pterígio/fisiopatologia , Raios UltravioletaRESUMO
Since its introduction to the United States in 1999, West Nile virus (WNV) has become endemic in North America and has emerged as the most common cause of epidemic meningoencephalitis in North America and the leading cause of arboviral encephalitis in the United States. West Nile virus is maintained in nature by cycling between mosquito vectors and bird hosts; humans are incidental hosts. Transmission to humans occurs predominantly after a bite from an infected mosquito but has also occurred via transfusion of blood products, via organ transplantation from infected donors, transplacentally, and percutaneously through occupational exposure. Approximately one of 150 patients develops central nervous system manifestations, including meningitis, encephalitis, and acute flaccid paralysis/poliomyelitis. Risk factors for neuroinvasive disease include older age and immunosuppression. Imaging findings are nonspecific, and cerebrospinal fluid findings include pleocytosis, elevated protein, and normal to decreased glucose. The diagnosis is made in most patients on serological examination. Reverse transcription polymerase chain reaction tests are useful to screen blood products and for surveillance of birds and mosquitoes. The pathological findings are typical of a viral meningoencephalitis and include microglial nodules, perivascular chronic inflammation, and variable neuronal loss with necrosis or neuronophagia. Treatment is largely supportive, and control of the mosquito vectors may reduce the incidence of human infections.
Assuntos
Febre do Nilo Ocidental/epidemiologia , Febre do Nilo Ocidental/patologia , Animais , Humanos , Febre do Nilo Ocidental/diagnóstico , Vírus do Nilo Ocidental/genéticaRESUMO
PURPOSE: Malformations of cortical development (MCD) (cortical dysplasias) are well-recognized causes of intractable epilepsy. Although a histologic classification system for MCD has been proposed by Palmini et al. (Neurology; 2004; 62:S2), studies to date have not assessed reproducibility. The purpose of this study was to analyze inter- and intraobserver agreement among eight experienced neuropathologists (NPs) with respect to this classification system. METHODS: Sections from 26 epilepsy resections were selected to represent the range of pathologies described by Palmini et al. Recuts of single sections from each case were sent to the NPs to classify. The slides were resent at a later date for reclassification. Kappa analysis for both inter- and intraobserver concordance was performed. RESULTS: Interobserver agreement was moderate (kappa = 0.4968). There was > or =62.5% (5 of 8 NPs) agreement for 19 of 26 cases. The greatest concordance was present when making focal cortical dysplasia (FCD) types IIA/B classifications (12 of the 14 cases with > or =75% consensus). Mild MCD (types I/II) and FCD types IA/B classifications were the least reproducible, and used most frequently in cases without consensus. Intraobserver concordance was moderate to very good (range kappa = 0.4654-0.8504). The category with the fewest classification changes made on reevaluation was FCD type IIB (4.2%), whereas that with the most changes was mild MCD (types I/II) (52.9%). DISCUSSION: Interobserver concordance using this approach was moderate. The classification categories with the greatest concordance were FCD type IIA/B, and the least, mild MCD and FCD types IA/B. In addition, difficulty in differentiating Mild MCD/FCD type I lesions from normal and/or gliotic tissue was noted.
Assuntos
Córtex Cerebral/patologia , Epilepsias Parciais/patologia , Malformações do Desenvolvimento Cortical/patologia , Córtex Cerebral/cirurgia , Consenso , Epilepsias Parciais/diagnóstico , Epilepsias Parciais/cirurgia , Gliose/patologia , Humanos , Malformações do Desenvolvimento Cortical/classificação , Malformações do Desenvolvimento Cortical/diagnóstico , Malformações do Desenvolvimento Cortical/epidemiologia , Neurônios/patologia , Variações Dependentes do Observador , Patologia Clínica , Reprodutibilidade dos Testes , Terminologia como AssuntoRESUMO
OBJECTIVES: To determine whether a longitudinal, case-based evaluation system can predict acquisition of competency in surgical pathology and how trainees at risk can be identified early. DESIGN: Data were collected for trainee performance on surgical pathology cases (how well their diagnosis agreed with the faculty diagnosis) and compared with training outcomes. Negative training outcomes included failure to complete the residency, failure to pass the anatomic pathology component of the American Board of Pathology examination, and/or failure to obtain or hold a position immediately following training. FINDINGS: Thirty-three trainees recorded diagnoses for 54â326 surgical pathology cases, with outcome data available for 15 residents. Mean case-based performance was significantly higher for those with positive outcomes, and outcome status could be predicted as early as postgraduate year-1 (P â=â .0001). Performance on the first postgraduate year-1 rotation was significantly associated with the outcome (P â=â .02). Although trainees with unsuccessful outcomes improved their performance more rapidly, they started below residents with successful outcomes and did not make up the difference during training. There was no significant difference in Step 1 or 2 United States Medical Licensing Examination (USMLE) scores when compared with performance or final outcomes (P â=â .43 and P â=â .68, respectively) and the resident in-service examination (RISE) had limited predictive ability. DISCUSSION: Differences between successful- and unsuccessful-outcome residents were most evident in early residency, ideal for designing interventions or counseling residents to consider another specialty. CONCLUSION: Our longitudinal case-based system successfully identified trainees at risk for failure to acquire critical competencies for surgical pathology early in the program.
RESUMO
Rare cases of West Nile virus (WNV)-associated inflammation outside the central nervous system (CNS) have been reported. We evaluated the systemic distribution of WNV in postmortem tissues during encephalitis in six patients using immunohistochemistry. WNV antigens were detected in neurons of CNS (all 6 cases), kidney (4 cases), lungs (2 cases), pancreas (2 cases), thyroid (2 cases), intestine (2 cases), stomach (1 case), esophagus (1 case), bile duct (1 case), skin (1 case), prostate (1 case) and testis (1 case). In systemic organs epithelial cells were infected. In none of the six cases were viral antigens identified in hepatocytes, heart, adrenal gland, nerves, skeletal muscles, bone, vessels and fat. All cases in which viral antigens were identified in systemic organs in addition to CNS were severely immunocompromised transplant recipients. With the exception of testis and brain, most foci of infection were not associated with inflammation. While the absence of inflammation may in part be due to patient immunosuppression or to possible transient nature of any host response, compartmentalization of viral antigen to the luminal region of epithelial cells may sequester WNV from immune recognition. Comparison of our findings with previous reports suggests that patients with WNV encephalitis can have widespread systemic infection.
Assuntos
Antígenos Virais/imunologia , Vísceras/virologia , Febre do Nilo Ocidental/complicações , Vírus do Nilo Ocidental/imunologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Autopsia , Encéfalo/imunologia , Encéfalo/patologia , Encéfalo/virologia , Progressão da Doença , Células Epiteliais/imunologia , Células Epiteliais/patologia , Células Epiteliais/virologia , Evolução Fatal , Feminino , Humanos , Hospedeiro Imunocomprometido/imunologia , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Viremia/patologia , Viremia/fisiopatologia , Viremia/virologia , Vísceras/imunologia , Vísceras/patologia , Febre do Nilo Ocidental/imunologia , Febre do Nilo Ocidental/patologiaRESUMO
Identification of targets and delivery platforms for gene therapy of neurodegenerative disorders is a clinical challenge. We describe a novel paradigm in which the neuroprotective gene is the herpes simplex virus type 2 (HSV-2) antiapoptotic gene ICP10PK and the vector is the growth-compromised HSV-2 mutant DeltaRR. DeltaRR is delivered intranasally. It is not toxic in rats and mice. ICP10PK is expressed in the hippocampus of the DeltaRR-treated animals for at least 42 days in the absence of virus replication and late virus gene expression. Its expression is regulated by an AP-1 amplification loop. Intranasally delivered DeltaRR prevents kainic acid-induced seizures, neuronal loss, and inflammation, in both rats and mice. The data suggest that DeltaRR is a promising therapeutic platform for neurodegenerative diseases.
Assuntos
Terapia Genética , Vetores Genéticos/farmacologia , Herpesvirus Humano 2/genética , Neurônios/efeitos dos fármacos , Convulsões/prevenção & controle , Administração Intranasal , Animais , Chlorocebus aethiops , Vetores Genéticos/administração & dosagem , Vetores Genéticos/uso terapêutico , Hipocampo/citologia , Hipocampo/metabolismo , Humanos , Ácido Caínico/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Técnicas de Cultura de Órgãos , Células PC12 , Ratos , Ratos Sprague-Dawley , Deleção de Sequência , Resultado do Tratamento , Células VeroRESUMO
We present the case of a 35-year-old man with a new onset of seizure disorder who was found to harbor an intraparenchymal retained foreign body related to remote orbital trauma. Imaging revealed a rim-enhancing anterior medial temporal lobe mass. Histologic evaluation of the resected mass showed evidence of acute and chronic inflammation with associated foreign material. The patient described a "bar fight" 16 years previously in which he received a blow to the orbit with a pool cue stick. The diagnosis of a foreign body reaction should be considered when an intraparenchymal mass is identified in this location.
Assuntos
Corpos Estranhos/etiologia , Órbita/lesões , Lobo Temporal , Ferimentos Penetrantes/complicações , Adulto , Epilepsia Generalizada/etiologia , Corpos Estranhos/diagnóstico , Corpos Estranhos/diagnóstico por imagem , Corpos Estranhos/patologia , Reação a Corpo Estranho/etiologia , Reação a Corpo Estranho/patologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Tomografia Computadorizada por Raios XRESUMO
In recent years, numerous new entities or variants of recognized central nervous system tumors have been described in the literature, and the morphologic spectrum of these neoplasms is delineated incompletely. The accurate diagnosis and classification of these lesions is important to ensure that patients receive adequate therapy and prognostic information. The clinicopathologic features and differential diagnosis of 4 new entities, including the chordoid glioma of the third ventricle, cerebellar liponeurocytoma, atypical teratoid/rhabdoid tumor, and papillary glioneuronal tumor, are discussed in this review.
Assuntos
Neoplasias do Sistema Nervoso Central/classificação , Neoplasias do Sistema Nervoso Central/diagnóstico , Adulto , Neoplasias Cerebelares/classificação , Neoplasias Cerebelares/diagnóstico , Criança , Cordoma/classificação , Cordoma/diagnóstico , Diagnóstico Diferencial , Feminino , Ganglioglioma/classificação , Ganglioglioma/diagnóstico , Glioma/diagnóstico , Glioma/patologia , Humanos , Neoplasias Hipotalâmicas/classificação , Neoplasias Hipotalâmicas/diagnóstico , Masculino , Meduloblastoma/classificação , Meduloblastoma/diagnóstico , Prognóstico , Tumor Rabdoide/classificação , Tumor Rabdoide/diagnóstico , Teratoma/classificação , Teratoma/diagnóstico , Terceiro Ventrículo/patologiaRESUMO
Clear cell meningioma (CCM) is a rare variant of meningioma characterized by sheets of polygonal cells with clear cytoplasm, a feature attributable to its high glycogen content. Authors have described its propensity to recur and metastasize despite its benign pathological characteristics. Clinical response to radiation in these reports has varied. The authors present the case of a 7-year-old girl with a large petroclival CCM who underwent a staged subtotal resection and subsequent gamma knife surgery (GKS). Initially, the residual tumor decreased in size, but 6 years later, it had regrown (9 mm in size). A second GKS treatment was performed and the mass completely regressed without further complication. The findings in this case suggest that GKS is a safe and effective adjunct for residual and recurrent CCM after resection. The delayed recurrence also emphasizes the importance of undertaking close follow-up examination after treating this potentially aggressive variant of meningioma.
Assuntos
Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Recidiva Local de Neoplasia/cirurgia , Neoplasia Residual/cirurgia , Técnicas Estereotáxicas , Ângulo Cerebelopontino/patologia , Ângulo Cerebelopontino/cirurgia , Criança , Dominância Cerebral/fisiologia , Feminino , Seguimentos , Glicogênio/metabolismo , Humanos , Aumento da Imagem , Imageamento por Ressonância Magnética , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/patologia , Meningioma/diagnóstico , Meningioma/patologia , Recidiva Local de Neoplasia/diagnóstico , Neoplasia Residual/diagnóstico , Exame Neurológico , Reoperação , Lobo Temporal/patologia , Lobo Temporal/cirurgia , Tomografia Computadorizada por Raios XRESUMO
We report the case of a 47-year-old man who developed progressive multifocal leukoencephalopathy (PML) after receiving immuno-suppressive therapy for renal transplantation. The patient presented with a focal seizure and cognitive changes 5 months post-transplantation. He was found to have enhancing lesions in the parietal lobe and typical findings of PML in a brain biopsy. Immunosuppression was discontinued and the neurological symptoms gradually resolved over a period of 4 weeks. The patient is free of any neurological symptoms 36 months after the diagnosis of PML and imaging studies demonstrate resolution of the PML lesions. The patient returned to hemodialysis 3 months after immunosuppression was discontinued. We also present a review of the literature on PML in renal transplant recipients.
Assuntos
Transplante de Rim/efeitos adversos , Leucoencefalopatia Multifocal Progressiva/etiologia , Leucoencefalopatia Multifocal Progressiva/terapia , Biópsia , Encéfalo/patologia , Humanos , Imunossupressores/farmacologia , Vírus JC/metabolismo , Masculino , Pessoa de Meia-Idade , Nefrite Hereditária/complicações , Oligodendroglia/metabolismo , Complicações Pós-Operatórias , PrognósticoRESUMO
Herpes simplex virus type 1 (HSV-1) triggered apoptosis in hippocampal cultures, as determined by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) and immunohistochemistry with antibody specific for the large fragment of activated caspase 3. The levels of phosphorylated (activated) c-Jun N-terminal kinase (JNK) were also increased in HSV-1-infected hippocampal cultures as were the levels of activated c-Jun, its target. JNK activation was involved in HSV-1-induced apoptosis as evidenced by apoptosis inhibition with the JNK inhibitor SP600125. HSV-2 activated the mitogen-activated protein kinase/extracellular regulated protein kinase (MEK/ERK) survival pathway and did not trigger apoptosis in hippocampal cultures. The MEK specific inhibitor U0126 inhibited ERK activation and caused a significant increase in the percent TUNEL(+) cells in HSV-2-infected cultures, indicating that the failure of HSV-2 to trigger apoptosis is due to its ability to activate the MEK/ERK survival pathway. JNK was also activated in brain tissues from patients with HSV-associated acute focal encephalitis (HSE) that were positive for HSV-1 antigen. JNK activation correlated with apoptosis, as determined by immunohistochemistry with antibody to activated caspase 3 or cleaved poly (ADP-ribose) polymerase (PARP). The data suggest that HSE has an apoptotic component that may contribute to disease pathogenesis.
Assuntos
Encefalite Viral/patologia , Herpes Simples/patologia , Herpesvirus Humano 1 , MAP Quinase Quinase Quinase 1 , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Neurônios/virologia , Animais , Apoptose/fisiologia , Caspase 3 , Caspases/metabolismo , Células Cultivadas , Encefalite Viral/metabolismo , Herpes Simples/metabolismo , Herpesvirus Humano 2 , Hipocampo/citologia , Marcação In Situ das Extremidades Cortadas , Proteínas Quinases JNK Ativadas por Mitógeno , Proteínas Quinases Ativadas por Mitógeno/antagonistas & inibidores , Neurônios/enzimologia , Neurônios/patologia , Poli(ADP-Ribose) Polimerases/metabolismo , Proteínas Serina-Treonina Quinases/metabolismo , Ratos , Ratos Sprague-DawleyRESUMO
The neuropathology of the primary dystonias is not well understood. We examined brains from identical twins with DYT1-negative, dopa-unresponsive dystonia. The twins exhibited mild developmental delays until age 12 years when they began developing rapidly progressive generalized dystonia. Genetic, metabolic, and imaging studies ruled out known causes of dystonia. Cognition was subnormal but stable until the last few years. Death occurred at ages 21 and 22 years. The brains were macroscopically unremarkable. Microscopic examination showed unusual glial fibrillary acidic protein-immunoreactive astrocytes in multiple regions and iron accumulation in pallidal and nigral neurons. However, the most striking findings were 1) eosinophilic, rod-like cytoplasmic inclusions in neocortical and thalamic neurons that were actin depolymerizing factor/cofilin-immunoreactive but only rarely actin-positive; and 2) abundant eosinophilic spherical structures in the striatum that were strongly actin- and actin depolymerizing factor/cofilin-positive. Electron microscopy suggested that these structures represent degenerating neurons and processes; the accumulating filaments had the same dimensions as actin microfilaments. To our knowledge, aggregation of actin has not been reported previously as the predominant feature in any neurodegenerative disease. Thus, our findings may shed light on a novel neuropathological change associated with dystonia that may represent a new degenerative mechanism involving actin, a ubiquitous constituent of the cytoskeletal system.
Assuntos
Actinas/análise , Distúrbios Distônicos/metabolismo , Distúrbios Distônicos/patologia , Proteínas dos Microfilamentos/análise , Fatores de Despolimerização de Actina , Adulto , Antagonistas Colinérgicos/uso terapêutico , Distúrbios Distônicos/tratamento farmacológico , Saúde da Família , Humanos , Corpos de Inclusão/química , Corpos de Inclusão/patologia , Corpos de Inclusão/ultraestrutura , Microscopia Eletrônica , Degeneração Neural/tratamento farmacológico , Degeneração Neural/metabolismo , Degeneração Neural/patologia , Neurônios/química , Neurônios/patologia , Neurônios/ultraestrutura , Neurópilo/química , Neurópilo/patologia , Neurópilo/ultraestrutura , Parassimpatolíticos/uso terapêutico , Fenótipo , Gêmeos MonozigóticosRESUMO
Thrombomodulin (TM), a vascular endothelial receptor, terminates the actions of thrombin and accelerates activated protein C formation. TM is ubiquitous throughout the systemic microcirculation but is reduced in brain regions predisposed to lacunar infarction. We investigated whether TM is present within human nerve and differentially expressed according to vessel caliber and proximity to the blood-nerve barrier. Vascular endothelial TM was detected on sural nerve biopsies with immunohistochemistry. The proportion of TM-positive microvessels was expressed relative to total von Willebrand factor (vWF)-positive vessels. Although vWF was detectable in all microvessels, TM expression was absent from the perineurial vessels. TM was detected in 47% (15-80%, 95% confidence level) of larger epineurial arterioles, in 43% (30-61%) of smaller epineurial vessels, and in 30% (19-47%) of endoneurial vessels. These findings demonstrate that TM is present in human nerve microvasculature but is regionally deficient in proximity to the blood-nerve barrier, which may predispose nerve to microvascular ischemia in inflammatory/prothrombotic conditions.
Assuntos
Doenças do Sistema Nervoso Periférico/metabolismo , Nervo Sural/irrigação sanguínea , Nervo Sural/metabolismo , Trombomodulina/metabolismo , Trombose/metabolismo , Biópsia , Humanos , Microcirculação/fisiologia , Nervos Periféricos/metabolismo , Nervos Periféricos/patologia , Doenças do Sistema Nervoso Periférico/patologia , Nervo Sural/patologiaRESUMO
Human diabetic neuropathy is multifactorial in etiology, with ischemia as a final common pathology. Although impaired vascular endothelial cell function in diabetic microvascular injury is established, the role of thrombomodulin (TM)-dependent protein C antithrombotic mechanism in the pathogenesis of neuropathy is unclear. This neuropathologic case-control study investigated whether vascular endothelial TM expression is deficient in peripheral nerve microvessels in diabetic neuropathy. Sural nerve biopsies from 7 patients with diabetic neuropathy and 10 with axonal neuropathy without vasculopathy were immunostained with anti-TM and anti-von Willebrand factor (vWF; an endothelial cell marker) antibodies. The proportion of TM-positive microvessels was expressed relative to total vWF-staining vessels, according to vessel caliber and regional distribution within the nerve. In diabetic nerves compared with reference controls, the proportion of TM-positive endoneurial microvessels was 15-fold lower (0.02 vs. 0.30 in diabetic nerves vs. controls, P < 0.004), and the proportion of small-caliber epineurial microvessels was 10-fold lower (0.04 vs. 0.43, P < 0.001). No TM expression was detected at the perineurium in diabetic or control nerves. We demonstrate a substantial reduction of vascular endothelial TM expression throughout human diabetic neuropathy. These findings suggest that an impaired native TM-dependent protein C antithrombotic mechanism may contribute to microvascular ischemia in the pathogenesis of diabetic neuropathy.